Skip to content

Companies Investors Funds People Markets

/

Loading company…

Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute
API

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

© 2026 CapbaseData CC BY-NC 4.0 · Code AGPL-3.0support@capbase.fyi

Lyric Pharmaceuticals, Inc. — Funding, Investors & Profile — Capbase

← All companies

L

Company

Lyric Pharmaceuticals, Inc.

Lyric Pharmaceuticals is a clinical-stage biopharmaceutical company developing gastrointestinal therapeutics, including LP101.

About

Established in 2013 and based in San Francisco, US, Lyric Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing gastrointestinal therapeutics, including LP101 (ulimorelin). In April 2017 it raised USD 18.97 million in Series A funding from Aperture Venture Partners, RiverVest Ventures, Santé Ventures and Third Point Ventures.

3Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.